Skip to content
Companies

Lifeward

Robotic exoskeletons for spinal cord injury and stroke

Raised to date

$31.2M

across 2 Form D filings

Investors
2
Last filed
Jul 8, 2026

About

Lifeward Ltd. is a Nasdaq-listed medical device company (LFWD) that develops and sells wearable robotic exoskeletons and other rehabilitation and recovery technology. It was founded as ReWalk Robotics in 2001 and completed its rename to Lifeward in September 2024 after acquisitions broadened the portfolio beyond exoskeletons. Its products serve people with spinal cord injury, stroke, and other neurological or orthopedic conditions, sold to rehabilitation clinics and to individuals. It is headquartered at 2 Cabot Road in Hudson, Massachusetts, with additional offices in Berlin, Germany and Yokneam Ilit, Israel.

One portfolio spanning the rehabilitation continuum from clinic to home, anchored by the ReWalk personal exoskeleton, the only product line of its kind marketed for personal use by people with spinal cord injury in the US.

Funding

No target, first sold Mar 2026$20M soldMar 2026JunSep
Now
  • EquityFiled Jul 8, 2026Form D
    $11.2M/ no target
  • EquityFiled Apr 2, 2026Form D
    $20M/ no target

Product

ReWalk Personal Exoskeleton

Wearable robotic medical device

A wearable robotic exoskeleton that provides powered hip and knee motion, enabling individuals with spinal cord injury to stand upright, walk, turn, and climb and descend stairs. The seventh generation, ReWalk 7, became available nationwide in the US in April 2025.

  • Powered hip and knee motion
  • Stair ascent and descent
  • Designed for personal, at-home use rather than clinic-only

Built for

Rehabilitation hospitals and clinics, plus individuals with spinal cord injury, stroke, brain injury, or multiple sclerosis, including veterans.

People on file